Supplementary Material

No data

Abstract

Ceftriaxone, third-generation cephalosporin, is widely used in patients for the treatment of serious gram-negative infection without a dose adjustment for renal insufficiency. Ceftriaxoneinduced neurotoxicity, particularly non-convulsive status epilepticus (NCSE), has rarely been reported. We present a case of ceftriaxoneinduced non-convulsive status epilepticus in treatment of complicated urinary tract infection and acute on chronic kidney disease (CKD) for a 71-year-old woman. The prognosis of NCSE is poor in elderly patients due to a delay in diagnosis and treatment may be associated with increased mortality or neuronal loss, as well as dysfunction of cognitive and behavioral abilities. Emergent and continuous electroencephalogram monitoring can assist physicians in both early recognition and accurate management of NCSE. Immediate withdrawal of cephalosporin is necessary. Antiepileptic drugs may be helpful but data of prognosis are still lacking. Physicians should be aware of the potential neurotoxic complication in those with high risks (elderly, CKD, or prior central nervous system conditions).